Front Row Advisors’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-18
| Closed | -$2.57K | – | 862 |
|
2024
Q2 | $2.57K | Sell |
18
-1
| -5% | -$143 | ﹤0.01% | 826 |
|
2024
Q1 | $2.97K | Buy |
+19
| New | +$2.97K | ﹤0.01% | 799 |
|
2023
Q4 | – | Sell |
-9
| Closed | -$1.62K | – | 829 |
|
2023
Q3 | $1.62K | Sell |
9
-3
| -25% | -$540 | ﹤0.01% | 831 |
|
2023
Q2 | $2K | Hold |
12
| – | – | ﹤0.01% | 832 |
|
2023
Q1 | $3K | Sell |
12
-1
| -8% | -$250 | ﹤0.01% | 791 |
|
2022
Q4 | $3K | Sell |
13
-2
| -13% | -$462 | ﹤0.01% | 756 |
|
2022
Q3 | $2K | Sell |
15
-2
| -12% | -$267 | ﹤0.01% | 845 |
|
2022
Q2 | $3K | Sell |
17
-3
| -15% | -$529 | ﹤0.01% | 780 |
|
2022
Q1 | $4K | Hold |
20
| – | – | ﹤0.01% | 778 |
|
2021
Q4 | $5K | Hold |
20
| – | – | ﹤0.01% | 763 |
|
2021
Q3 | $7K | Sell |
20
-3
| -13% | -$1.05K | ﹤0.01% | 674 |
|
2021
Q2 | $6K | Buy |
23
+4
| +21% | +$1.04K | ﹤0.01% | 717 |
|
2021
Q1 | $7K | Hold |
19
| – | – | ﹤0.01% | 656 |
|
2020
Q4 | $5K | Sell |
19
-1
| -5% | -$263 | ﹤0.01% | 702 |
|
2020
Q3 | $6K | Buy |
+20
| New | +$6K | ﹤0.01% | 661 |
|